Journal of Medicinal Chemistry p. 2798 - 2807 (1990)
Update date:2022-08-04
Topics:
Gapinski, D. Mark
Mallett, Barbara E.
Froelich, Larry L.
Jackson, William T.
A series of lipophilic benzophenone dicarboxylic acid derivatives was prepared which inhibited the binding of the potent chemotaxin leukotriene B4 to its receptor(s) on intact human neutrophils.With a radioligand-binding assay as a measure of receptor affinity, a structure-activity relationship for this series was investigated.Both acidic residues were required for receptor-binding activity.The relative orientation of the two acidic groups was important for optimal binding.Replacement of the carbonyl group of the benzophenone with a variety of polar and nonpolar linking groups lead to only small changes in binding affinity, indicating the linking group may not be involved in receptor recognition.Further structure-activity relationships within this series are reported in an accompanying paper.
View MoreContact:+86 21 34123252
Address:14, 4580 Dushi, Shanghai, China
Golden Union Agrochemical Import and Export Co., Ltd.
Contact:86-755-23910527
Address:Room 1106, Tower 3A, Excellence Century Center, Futian District, Shenzhen, China
Jinan Decheng Hemu Medical Technology Co.,Ltd.
Contact:+86-531-68650525
Address:NO.554 Zhengfeng Road High-new Technology Development Zone
Binzhou Holly Pharmaceutical Co.,Ltd.
Contact:74517
Address:No.15 Dapu Road,Huangpu District Shanghai,P.R.China
Shenyang Xinyihan Chemical Technology Co., Ltd.
Contact:+86-18525026267
Address:362, aigongbeijei street 23 , tiexi district,Shenyang, Liaoning, China
Doi:10.1016/S0040-4020(01)82039-1
(1990)Doi:10.1002/jhet.5570280133
(1991)Doi:10.1055/s-1990-26868
(1990)Doi:10.1016/0008-6215(90)84227-L
(1990)Doi:10.1248/cpb.38.1100
(1990)Doi:10.1016/j.jorganchem.2011.01.026
(2011)